# Kaiser Permanente of the Mid-Atlantic States IRB #7 – FDA Inspection, Feb 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/kaiser-permanente-of-the-mid-atlantic-states-irb-7/9411ccfd-8d26-4c76-b589-f6c782b26581
Source feed: FDA_Inspections

> FDA inspection 1232973 of Kaiser Permanente of the Mid-Atlantic States IRB #7, February 26, 2024. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232973
- Company Name: Kaiser Permanente of the Mid-Atlantic States IRB #7
- Inspection Date: 2024-02-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Citation Count: 0

## Related Documents

- FDA Inspection 1028527 - 2017-10-10

## Related Officers

- [Company Rep](https://www.keypedia.com/people/brittany-l-carpenter/600db4d0-0b6b-435f-b511-2ca10f292d5d)
- [Company Rep](https://www.keypedia.com/people/melanie-n-daniels/51d7ddf0-f1af-4e42-ba4c-9a18200f42a9)

Company: https://www.keypedia.com/companies/kaiser-permanente-of-the-mid-atlantic-states-irb-7/dbeb21fe-cf58-4b63-8bbc-80cea2ba57a7